Anyone who has ever played a racket sport, baseball, cricket, and/or golf can attest to experiencing the "sweet spot"-that place where the least jolt is felt on contact. In this issue of Blood, Chen et al show how sugar-decorated liposomes can be used to deliver doxorubicin in a targeted manner to malignant B cells, thus limiting the systemic jolt of this potent cytotoxic agent.
展开▼
